Opaleye Management Inc. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 45 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$6,724,000
+4808.0%
3,171,8000.0%0.88%
+3151.9%
Q3 2020$137,000
-81.6%
3,171,800
+1053.4%
0.03%
-85.8%
Q3 2018$745,000
-100.0%
275,000
+111.5%
0.19%
-85.5%
Q4 2013$1,670,500,000130,0001.31%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders